Introduction {#S0001}
============

Diabetes mellitus and obesity represent paradigmatic examples of systemic multifactorial chronic diseases, whose clinical characteristics lead to skin disturbances, which are often dependent on overlapping pathogenic mechanisms.[@CIT0001]

In both pathologies, the cutaneous system undergoes progressive changes, which are closely related to the severity and duration of the underlying chronic diseases.[@CIT0002]

Chronic hyperglycemia, through many pathogenic pathways, determines the development of systemic chronic complications that affect many systems and organs.[@CIT0003] The skin, which is the largest organ in the body, is also a target for complications.[@CIT0004] The non-enzymatic glycosylation of skin proteins, with the production of advanced glycosylation end products (AGEs), induces an increased production of reactive oxygen species (ROS) and possible disturbances in the balance of nitric oxide (NO).[@CIT0005] These same mechanisms are involved in determining skin complications, in particular increased levels of AGEs seem to play a crucial role.[@CIT0006] In fact when structural skin proteins, such as collagen, undergo glycosylation, they lose their elasticity and become insoluble and resistant to degradation and turnover. At the same time polyneuropathy and macroangiopathy also exert their effects on the skin.[@CIT0007] Neuropathy leads to a reduction in sensitive innervation, which is present for an initial period of years after a diagnosis of diabetes.[@CIT0008] Microvessels show homogeneous thickening of the basement membrane and of the walls of small-caliber vessels together with increased space between endothelial cells and pericytes in post-capillary veins.[@CIT0009] The impact on skin function is the consequence of this structural modification such as increased capillary permeability and basal pressure values with chronic interstitial oedema.[@CIT0010]

Obesity is characterized by insulin resistance and compensatory hyperinsulinemia,[@CIT0011] which in turn lead to changes in the structure and morphology of the skin.[@CIT0012] The first detectable shift is the loss of function of the skin barrier with an increase in trans-epidermal water loss.[@CIT0013] At the microcirculatory level, an increase in cutaneous blood flow has been described both in basal and peak values together with a compensatory reduction in the mean flow velocity.[@CIT0014] These changes appear to be related to changes in parasympathetic nerve activity,[@CIT0015] while the sympathetic branch is constitutively activated with a chronic increase in sweat gland secretion, especially at the palmar surface of the hands and plantar region of the feet.[@CIT0016] The clinical result consists of both skin diseases that are common to non-obese subjects and which are generally exacerbated by the overlap of obesity, and by diseases more closely related to the pathophysiological picture of obesity and insulin resistance.[@CIT0017]

Materials and Methods {#S0002}
=====================

The aims of our study were to evaluate the impact of diabetes mellitus and obesity on skin and subcutaneous tissues. In particular, we can identify:

Primary outcome: to explore the changes induced by diabetes mellitus and obesity on the cutaneous and subcutaneous lower limb system.

Secondary outcome: to evaluate the impact on the differences observed among groups of, respectively, diabetes and obesity.

Patients and Methods {#S0002-S2001}
--------------------

Patients scheduled for bariatric surgery with or without diabetes mellitus were recruited from the Bariatric Surgery Department of our hospital and nonobese diabetic patients were recruited from the Diabetology Department. Healthy volunteers were also recruited as a control group.

The following inclusion criteria were considered: age, between 18 and 65 years, diabetes duration \>5 yrs, release of informed consent, compliance with study procedures and ability to walk without aids. Exclusion criteria were: active ulceration or history of foot ulcer or foot and leg surgery, Charcot neuro-osteoarthropathy, presence of peripheral arterial disease or severe diabetic retinopathy, active neoplasms, other skin diseases that might interfere with the study, inability to give consent, and life expectancy shorter than 1 year.

In accordance with the body mass index and the presence or absence of diabetes, patients were divided into four groups as reported in [Table 1](#T0001){ref-type="table"}.Table 1Group Distribution According to Body Mass Index (BMI) and Presence of DiabetesGroupDiabetesObesity (Body Mass Index)1Yes (\>5 yrs)Yes (38--47 Kg/m^2^)2NoYes (38--47 Kg/m^2^)3Yes (\>5 yrs)No (\< 26 Kg/m^2^)4NoNo (\< 26 Kg/m^2^)

Study Procedures {#S0002-S2002}
----------------

After approval by the ethics committee of Pisa University Hospital and the release of the written informed consent, all the patients included in the study underwent a complete physical examination, measurement of anthropometric parameters, a cutaneous physical examination and ultrasound foot assessment. All measurements were taken of both the right (R) and left (L) foot and leg, and were analyzed separately. Measurements were performed after 15 mins of acclimatization in a consultation room where temperature and relative humidity were adjusted to 21±1°C and 50±3%, respectively. [Figure 1](#F0001){ref-type="fig"} illustrates the practical execution of the various assessments.Figure 1Practical assessment of anthropometric parameters (**A**), skin temperature (**B**), skin hardness (**C**), osteoarticular parameters (**D**--**F**) and ultrasound analysis at dorsum of the foot (**G**), at plantar surface (**H**) and Achilles tendon (**I**).

The study was conducted in accordance with Good clinical practice and Helsinki declaration principles.

Physical Complete Examination {#S0002-S2003}
-----------------------------

The complete clinical history of each patient was analysed both systemically and focused on lower limbs. Patients were also submitted to a complete objective examination. Arterial blood pressure and heart rate, both supine and upright were recorded. Arterial blood pressure was measured first supine, after 10 mins of rest with eyes closed in a dark and silent environment, by an aneroid sphygmomanometer. After the first measurement, the patient was positioned upright and the pressure measurement was repeated, within 2 mins of standing. The results were the mean of three consecutive measurements at a distance of 2 mins from each other, obtained by adding the values together and dividing by three.

Anthropometric Parameters {#S0002-S2004}
-------------------------

We evaluated the circumference of the foot at the dorsal region, over the prominence of the medial cuneiform bone, and the circumference of the leg at the ankle, immediately above the inter-malleolar line and at the calf. The latter measurement was obtained with the patient standing with his/her feet 25 cm apart in a relaxed position, with the weight evenly distributed on both feet. The tape was positioned around the calf at the widest part, after ensuring that the tape was horizontal around the calf, and by moving it up and down to locate the maximum circumference. The length of the foot was then measured, as the linear distance from the posterior point of the heel to the most anterior point of the longest toe (first or second) measured parallel to the foot axis.

All evaluations were performed using an anthropometric tape on bare skin. The results were the mean of three consecutive measurements, obtained by adding the values and dividing by three.

Cutaneous Physical Examination {#S0002-S2005}
------------------------------

The temperature was measured using an infrared thermometer (Braun -- Kromberg -- Germany), and hardness was measured using a portable shore durometer (O.M.A.G. -- Varese -- Italy). Evaluations were performed in a prone position, after 10 mins of rest, and the instruments were positioned on the plantar surface of the foot at median points of the lines joining the center of the calcaneum with the first and fifth metatarsal-phalangeal joints. Skin hydration was evaluated using a score ranging from 1 to 5 for both feet as previously described ([Table 2](#T0002){ref-type="table"}[@CIT0018]). The reported values represent the mean of four different values registered at the plantar surface of the heel, under the scaphoid region and at the 1st and 5th metatarsal heads.Table 2Skin Hydration Score[@CIT0018]ScoreDefinitionCharacteristics1AnhydrosisAbsent sweating, fissuration, desquamation, anelastic skin, absent pliability.2HypohidrosisSweating present only after stimulation, reduction or absence of dermatoglyphics, low pliability3NormohydrationSpontaneous sweating, normal pliability and glyph, skin normoelastic4HyperhydrosisExcessive sweating after stimulation, hypertrophic dermatoglyphics, sporadic maceration in the interdigital areas5MacerationSpontaneous excessive sweating, diffuse maceration, wet skin, eventual eczema

Foot Cutaneous Ultrasound Evaluation {#S0002-S2006}
------------------------------------

We measured the thickness of the skin and subcutaneous tissue overall in the dorsal region of the feet at the intersection between the intermalleolar line and the line passing by the first intermetatarsal space. The skin and subcutis on the plantar surface were then measured at the intersection between the longitudinal axis of the calcaneum and the intermalleolar line, at the first and fifth metatarsal head and at the level of the plantar arch above the scaphoid. The thickness of the plantar fascia was also measured at the intersection between the longitudinal axis of the calcaneum and the intermalleolar line and at the level of the plantar arch above the scaphoid together with the thickness of the Achilles tendon at the posterodorsal tuberculum of the calcaneum ([Figure 2](#F0002){ref-type="fig"}).Figure 2Measurement of skin and subcutaneous tissue in dorsal foot region (**A**), heel region (**B**), under the scaphoid (**C**) and under the metatarsal heads (**D**); measurement of plantar fascia at heel (**E**) and under the scaphoid (**F**); measurement of Achilles tendon at its insertion (**G**).

The analysis was performed by a Logiq 7pro ultrasound system (GE Healthcare Medial systems -- Chicago, Illinois -- USA) using a 12 Mhz linear probe.

Statistical Analysis {#S0002-S2007}
--------------------

Quantitative variables were expressed as mean, median, and standard deviation, and qualitative variables as frequencies and percentages. Data were compared with the Chi-square and Fisher's exact tests for the categorical data, and with the Student's *t*-test for the continuous variables. The statistical analysis was performed with SAS software (SAS Institute, Cary, NC). A p value of less than 0.05 was considered statistically significant.

Results {#S0003}
=======

From March to October 2018, we enrolled 120 patients who respected all our inclusion and exclusion criteria. Details of the enrolled population are reported in [Figure 3](#F0003){ref-type="fig"}. [Table 3](#T0003){ref-type="table"} reports the main clinical and demographic characteristics.Table 3Group Distribution, Clinical Characteristics and Vital ParametersCharacteristicGroup 1Group 2Group 3Group 4pDiabetesYesNoYesNoObesityYesYesNoNoNumber of patients30303030--Mean age (yrs)45.0±6.847.3±8.351.0±4.536.5±8.40.01°BMI (Kg/m^2^)42.9±4.541.2±5.424.9±2.223.5±1.50.01\*Duration of diabetes (yrs)7±1--8±2----HbA1c (%)7.1±1.8--7.2±2.0----SBP supine141±23134±17129±29130±19nsDBP supine77±578±378±476±5nsSBP upright119±20125±19118±17129±17nsDBP upright74±975±773±1076±9nsDelta SBP23±56±418±83±20.01^\#^Heart rate supine65±1167±962±1474±8nsHeart rate upright74±1070±1177±876±9nsDelta heart rate9±63±211±52±10.02^§^[^1] Figure 3Consort diagram of the study population.

In terms of the general characteristics, patients differed in age (Group 3 vs Group 4, p\<0.01) and body mass index (p\<0.01 Group 1 vs Group 3 and Group 4; Group 2 vs Group 3 and Group 4), as expected in accordance with the study design. Among diabetic patients, we observed no differences in terms of duration of disease or glycemic control. The assessment of vital parameters did not show differences in terms of blood pressure or heart rate between the groups irrespective of the presence or absence of diabetic patients. Both obese and nonobese patients showed a significantly higher difference in systolic pressure from lying to standing position (p\<0.01 in Group 1 vs Group 2 and Group 4; Group 3 vs Group 2 and Group 4) and heart rate increase (p=0.02 Group 3 vs Group 2 and Group 4 and p\<0.01 in Group 1 vs Group 2 and Group 4).

No differences were observed regarding trauma history at the lower limbs or regarding skin or rheumatological diseases. No signs of lower limb vascular disease were detected, in particular all patients applicant for bariatric surgery underwent venous ultrasound analysis, negative for venous incontinence. All other patients did not present clinical signs of venous damage.

No differences were observed in all parameters among the sides of measurement. The results above were confirmed both in the right and left foot and leg.

Anthropometric Parameters {#S0003-S2001}
-------------------------

As expected, all circumferences were significantly higher in the obese groups, with no differences whether they were diabetic or not (for all parameters: p\<0.01 in Group 1 vs Group 3 and Group 4; Group 2 vs Group 3 and Group 4). No differences were observed regarding foot length. Details are reported in [Table 4](#T0004){ref-type="table"}.Table 4Differences in Anthropometric CharacteristicsCircumference (cm)Group 1Group 2Group 3Group 4pDiabetesYesNoYesNoObesityYesYesNoNoDorsal foot (R)25.5±3.626.2±1.420.8±1.421.1±1.30.01°Dorsal foot (L)26.1±3.825.6±1.820.6±1.419.9±1.20.01°Overmalleolar leg (R)28.2±2.927.6±1.020.9±1.620.5±1.20.01°Overmalleolar leg (L)26.8±3.127.3±1.421.1±1.421.4±1.10.01°Below-knee leg (R)44.5±4.643.1±3.032.6±3.133.8±3.90.01°Below-knee leg (L)44.1±3.443.5±1.333.6±1.131.9±1.50.01°Length of foot (R)28.5±2.328.2±2.028.0±2.628.4±2.9nsLength of foot (L)28.4±2.228.0±2.828.1±2.029±1.8ns[^2]

Cutaneous Physical Examination {#S0003-S2002}
------------------------------

No differences were observed between the groups regarding skin hardness, while skin temperature was significantly higher in all obese patients, irrespective of the presence of diabetes (1st metatarsal head, right foot: p=0.02 Group 1 vs Group 3 and Group 4 and Group 2 vs Group 3 and Group 4 - 1st metatarsal head, left foot: p=0.02 Group 1 vs Group 3 and Group 4 and Group 2 vs Group 3 and Group 4 -- 5th metatarsal head, right foot: p\<0.01 Group 1 vs Group 3 and Group 4 and Group 2 vs Group 3 and Group 4 -- 5th metatarsal head, right foot: p\<0.01 Group 1 vs Group 3 and Group 4 and Group 2 vs Group 3 and Group 4). Low scores in the skin hydration score indicated increased levels of anhydrosis in diabetic patients. However, unlike other parameters, diabetes exerted a synergistic effect when associated with obesity (Right foot: p\<0.01 Group 1 vs Group 3 and Group 4 and Group 2 vs Group 1 and Group 4 - Left foot: p\<0.01 Group 1 vs Group 3 and Group 4 and Group 2 vs Group 1 and Group 4). Data are detailed in [Table 5](#T0005){ref-type="table"}.Table 5Skin Evaluation in GroupsParameterGroup 1Group 2Group 3Group 4pDiabetesYesNoYesNoObesityYesYesNoNoTemperature I mts R31.3±4.733.9±3.828.2±3.828.4±3.50.02°Temperature I mts L31.3±4.533.8±3.927.9±2.927.3±2.40.02°Temperature V mts R30.3±4.933.1±4.827.3±3.527.0±3.00.01\*Temperature V mts L30.9±4.834.0±4.027.0±2.026.6±2.50.01\*Hardness I mts R19.9±4.720.3±5.319.8±4.619.0±4.2n.s.Hardness I mts L20.0±3.620.9±3.519.5±3.618.8±3.8n.s.Hardness V mts R29.9±6.630.1±6.629.5±7.529.2±7.0n.s.Hardness V mts L29.4±6.928.7±6.730.1±8.130.5±7.6n.s.Skin hydration score R1.1±0.42.0±0.52.1±0.62.6±0.50.01^\#^Skin hydration score L1.3±0.21.9±0.52.0±0.62.4±0.50.01^\#^[^3]

Foot Cutaneous Ultrasound Evaluation {#S0003-S2003}
------------------------------------

Ultrasound revealed an increase in the thickness of skin and subcutaneous tissues and plantar fascia in the heel region and under the scaphoid in all obese patients, irrespectively of the presence of diabetes. Both thickness of cutis and subcutaneous tissue were more important in obese patients at the heel region in the right (p\<0.01 Group 1 vs Group 3 and Group 4 and Group 2 vs Group 3 and Group 4) and left foot (p\<0.01 Group 1 vs Group 3 and Group 4 and Group 2 vs Group 3 and Group 4) and under the scaphoid in the right (p=0.03 Group 1 vs Group 3 and Group 4 and Group 2 vs Group 3 and Group 4) and left foot (p=0.03 Group 1 vs Group 3 and Group 4 and Group 2 vs Group 3 and Group 4).

Plantar fascia presented a similar pattern: it was thicker both at the heel in the right (p=0.02 Group 1 vs Group 3 and Group 4 and Group 2 vs Group 3 and Group 4) and left foot (p=0.02 Group 1 vs Group 3 and Group 4 and Group 2 vs Group 3 and Group 4) and, again, under scaphoid in the right (p=0.02 Group 1 vs Group 3 and Group 4 and Group 2 vs Group 3 and Group 4) and left foot (p=0.02 Group 1 vs Group 3 and Group 4 and Group 2 vs Group 3 and Group 4).

No differences associated with diabetes were reported between obese or not obese patients. Further details are reported in [Table 6](#T0006){ref-type="table"}.Table 6Differences in Ultrasound Evaluation Reported Refer to Obese vs Not Obese PatientsRegion (mm)Group 1Group 2Group 3Group 4pDiabetesYesNoYesNoObesityYesYesNoNoSkin Dorsal R0.33±0.080.32±0.080.29±0.070.29±0.08n.s. Dorsal L0.35±0.080.34±0.100.34±0.030.29±0.04n.s. Heel plantar R1.42±0.251.39±0.241.12±0.181.14±0.22\<0.01° Heel plantar L1.35±0.291.40±0.291.15±0.201.11±0.23\<0.01° Scaphoid plantar R0.68±0.200.67±0.250.60±0.140.63±0.150.03\* Scaphoid plantar L0.69±0.210.65±0.280.59±0.100.57±0.120.03\* I mts plantar R0.55±0.130.53±0.160.44±0.100.41±0.06n.s. I mts plantar L0.52±0.130.51±0.130.39±0.080.46±0.11n.s. V mts plantar R0.70±0.150.67±0.180.65±0.070.67±0.12n.s. V mts plantar L0.66±0.170.68±0.170.62±0.130.64±0.11n.s.Plantar Fascia Heel plantar fascia R0.34±0.070.32±0.090.26±0.050.28±0.060.02^\#^ Heel plantar fascia L0.34±0.100.35±0.130.28±0.030.27±0.050.02^\#^ Scaphoid plant fascia R0.18±0.040.17±0.020.13±0.030.13±0.040.02^\#^ Scaphoid plant fascia L0.20±0.050.19±0.050.15±0.060.14±0.040.02^\#^Achilles Tendon Achilles tendon R0.48±0.090.47±0.110.41±0.020.44±0.03n.s. Achilles tendon L0.48±0.100.46±0.120.42±0.050.44±0.06n.s.[^4]

The impact of, respectively, diabetes and obesity was explored with Cox regression analysis ([Table 7](#T0007){ref-type="table"}) that confirmed the influence of obesity and not of diabetes on anthropometric parameters, skin temperature and ultrasound analysis. Skin hydration was instead determined by both diabetes and obesity that acts together on this value.Table 7Cox Regression Model for Anthropometric Parameters, Skin Temperature, Skin Hydration and Ultrasound AnalysisCharacteristicsUnivariate (HR -- 95% CI)\
(HR - 95% CI)pMultivariate (HR -- 95% CI)\
(HR - 95% CI)pDorsal Foot Circumference Diabetes1.18 (0.76--1.30)0.43 Obesity1.35 (1.23--1.44)0.021.47 (1.33--1.66)0.02Overmalleolar Leg Circumference Diabetes1.38 (0.60--1.63)0.38 Obesity1.27 (1.15--1.39)0.021.56 (1.45--1.80)0.01Underknee Leg Circumference Diabetes1.35 (0.87--1.57)0.36 Obesity1.21 (1.05--1.42)0.021.33 (1.13--1.56)0.02Skin Temperature -- I Metatarsal Head Diabetes0.82 (0.38--1.88)0.70 Obesity1.42 (1.12--1.65)0.041.32 (1.10--1.44)0.04Skin Temperature - V Metatarsal Head Diabetes1.15 (0.69--1.37)0.31 Obesity1.37 (1.25--1.52)0.021.48 (1.35--1.60)0.02Skin Hydration Diabetes0.55 (0.38--0.76)0.040.78 (0.45--0.94)0.02 Obesity0.87 (0.75--0.96)0.020.65 (0.35--0.82)0.04Skin Thickness -- Heel Region Diabetes0.86 (0.56--1.34)0.46 Obesity1.37 (1.15--1.42)0.041.45 (1.29--1.67)0.02Skin Thickness -- Scaphoid Region Diabetes1.15 (0.66--1.45)0.30 Obesity1.32 (1.12--1.52)0.041.60 (1.38--1.79)0.02Fascia Thickness -- Heel Region Diabetes1.55 (0.91--1.77)0.32 Obesity1.43 (1.23--1.67)0.041.33 (1.21--1.53)0.04Fascia Thickness -- Scaphoid Region Diabetes1.32 (0.56--1.78)0.31 Obesity1.34 (1.12--1.65)0.041.45 (1.23--1.64)0.02

Discussion {#S0004}
==========

Diabetes and obesity are among the most frequent co-morbid chronic pathologies affecting millions of patients worldwide, such that the term "diabesity" has been created.[@CIT0019] Both pathologies are known to affect skin and musculoskeletal structures (MSS) by means of a variety of mechanisms.[@CIT0020] In our study, we evaluated four aspects of skin and MSS affected by obesity and diabetes: thickness, hydration, temperature and hardness, all related to the functional status of the foot ([Table 8](#T0008){ref-type="table"}).Table 8Summary of the Results of Our Study According to Groups and Parameters: - Neutral Effect, + Mild Increase, ++ Moderate Increase, +++ Severe IncreaseParameter (cm)Group 1Group 2Group 3Group 4pDiabetesYesNoYesNoObesityYesYesNoNoTemperature+++++\--0.01Hardness++\--NsHydration+++++++-0.01Thickness++++\--0.01

It is well known that obesity leads to musculoskeletal alterations in the feet and legs. Long-term exposure to an increased load on the feet leads to changes in the architecture and mechanical properties of the plantar fascia and heel pad.[@CIT0021] These modifications decrease the protective and supportive capacity of the plantar foot region, thus causing foot disorders.[@CIT0022]

Despite a number of studies investigating the role of plantar fascia in obese subjects in the literature, our study is the first to try to ascertain the role of diabetes in such a context and to differentiate the impacts of the two concomitant pathologies. Our data showed an increase both in plantar fascia, in the skin and subcutaneous tissue in severely obese patients compared to diabetic nonobese subjects and among obese subjects irrespectively of the presence of diabetes. The increase in plantar fascia thickness associated with severe obesity can be interpreted as a compensatory reaction for the elongation and deformation associated with increased loading and not solved by the reduction in plantar stiffness.[@CIT0023] On the other hand, in diabetics, an increased thickness of the tendons and plantar structures was found, related to the increase in proteins of the cutaneous structures.[@CIT0024] The complete absence of venous disease allowed us to exclude the impact of subcutaneous oedema in clinical findings. Our findings do not confirm the association between those two separate mechanisms in obese patients, in whom the mechanical components seem to play a major role.

The analysis of skin temperature showed an increase in all sites in all obese patients, irrespectively of the presence of diabetes. However, increased temperature today tends to be attributed to the inflammatory changes that precede the onset of an ulcer.[@CIT0025],[@CIT0026]

Skin hydration is an important feature of normal skin, since it provides a sufficient degree of elasticity to prevent fissurations.[@CIT0027] Both diabetes and obesity have been associated with a modification in skin hydration: diabetes with hypohidrosis because of the sympathetic denervation of sweat glands in the lower extremity, and obesity with hyperhidrosis due to the chronic systemic activation of sympathetic components of the autonomic nervous system.[@CIT0028]

In chronic phases, in patients at low risk of ulceration, the increase in skin temperature reflects the hemodynamic changes that are typical of obese patients at the microcirculatory level.[@CIT0029]

We measured the skin hydration score in our patients, which demonstrated normal hydration in the controls, moderate hypohidrosis in nonobese diabetic patients and obese nondiabetic patients, and severe hypohidrosis in obese diabetic patients, suggesting that diabetes exerts a synergistic effect when associated with obesity. To our knowledge, few analyses of skin hydration scores have been performed to date and this is the first time in which the two diseases have been compared. The main limitation of this analysis is represented by the differences in mean age among groups, nevertheless the strength of this association is quite controversial in scientific literature.[@CIT0030] On the other hand, while mean age was higher in not obese diabetic patients, the skin hydration is significantly lower in diabetic obese patients, further confirming the synergistic role exerted by the two diseases. The study result was an unexpected finding, since we would expect compensatory hyperhidrosis in obese patients. This could be the effect of the downregulation of sweat in the lower limbs secondary to hyper-sweating in the trunk, however this needs confirming.

We are aware of the limitations of our study, which is single-center based, and possibly biased by the selection of patients, who were mostly referred by other centers to ours both for diabetes care and especially for bariatric surgery.

Conclusions {#S0005}
===========

Our study has demonstrated how obesity takes the lead in determining morphostructural changes in skin and MSS and in functional changes in the microcirculatory compartment in the lower limbs of super-obese patients. This is without any significant additive effect of diabetes, which in turn significantly influences the clinical features when hydration is taken into consideration.

We are now planning a follow-up evaluation of the same cohort of patients after bariatric surgery, to test whether recovery from obesity could be associated with a normalization of the structural and morpho-functional parameters.
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[^1]: **Notes:** °Group 3 vs Group 1, Group 2 and Group 3 and Group 4 vs Group 1 and Group 2. \*Group 1 vs Group 3, Group 4 and Group 2 vs Group 3 and Group 4. ^\#^Group 1 vs Group 2 and Group 4 and Group 3 vs Group 2 and Group 4. ^§^Group 3 vs Group 2 and Group 4 and p\<0.01 in Group 1 vs Group 2.

    **Abbreviations:** BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure.

[^2]: **Note:** °Group 1 vs Group 3 and Group 4; Group 2 vs Group 3 and Group 4.

[^3]: **Notes:** °Group 1 vs Group 3 and Group 4; Group 2 vs Group 3 and Group 4. \*Group 1 vs Group 3 and Group 4; Group 2 vs Group 3 and Group 4. ^\#^Group 2 and Group 3 and Group 1 and Group 4.

    **Abbreviations:** R, right; L, left; mts, metatarsal.

[^4]: **Notes:** °Group 1 vs Group 3 and Group 4; Group 2 vs Group 3 and Group 4. \*Group 1 vs Group 3 and Group 4; Group 2 vs Group 3 and Group 4. **^\#^**Group 1 vs Group 3 and Group 4; Group 2 vs Group 3 and Group 4.

    **Abbreviations:** R, right; L, left; mts, metatarsal.
